目錄:MedChemExpress LLC>>信號通路>> Gadopentetate dimeglumine | MCE
CAS | 86050-77-3 | 純度 | ≥99.0% |
---|---|---|---|
分子量 | 938.0 | 分子式 | C??H??GdN?O?? |
供貨周期 | 現(xiàn)貨 | 規(guī)格 | 50 mg |
貨號 | HY-A0167 | 應用領域 | 醫(yī)療衛(wèi)生,化工,生物產(chǎn)業(yè),制藥 |
MCE 的所有產(chǎn)品僅用作科學研究或藥證申報,我們不為任何個人用途提供產(chǎn)品和服務。
產(chǎn)品活性:Gadopentetate dimeglumine (SH-L-451A) 用于核磁共振成像 (MRI) 中,更清晰地看到血管,器官和其他非骨組織。
研究領域:Others
作用靶點:Others
In Vitro: Gadobenate dimeglumine-enhanced MRI significantly improves cancer detection compared to gadopentetate dimeglumine-enhanced MRI, mammography, and ultrasound in a selected group of patients undergoing breast MRI for preoperative staging or because of inconclusive findings at conventional imaging. Interstitial MR lymphography with gadopentetate dimeglumine (Gd-DTPA) or gadoxetate disodium (Gd-EOB-DTPA) allows clear visualization of the lymphatic pathway in healthy mice, and no significant difference is found between the two agents. Their rapid kinetics limits the imaging timing window, however, facilitates repeated assessment in a single imaging session. Direct visualization of spilled gastrointestinal gadopentetate dimeglumine helps discriminate ischemic from control rats in this model.
相關產(chǎn)品:Drug Repurposing Compound Library Plus | FDA-Approved Drug Library Plus | FDA-Approved Drug Library Mini | Bioactive Compound Library Plus | FDA-Approved Drug Library | Anti-Cancer Compound Library | Drug Repurposing Compound Library | Macrocyclic Compound Library | NMPA-Approved Drug Library | FDA Approved & Pharmacopeial Drug Library | Drug-Induced Liver Injury (DILI) Compound Library | Food-Sourced Compound Library | FDA-Approved Anticancer Drug Library | Off-patent Drug Library | Antitumor agent-67 | Catechin 7-O-β-D-glucopyranoside | Carbobenzoxyproline | ATR-IN-9 | TBTDC | Peucenin 7-O-methyl ether | 6-Hydroxy-4-methylcoumarin | AMT-NHS | Nylidrin hydrochloride | D-(+)-Fucose | OVA Peptide (323-339) | Secretin (swine) | Bletilloside A | Transcriptional Intermediary Factor 2 (TIF2) (740-753) | Pep-1 (uncapped) | Aspochalasin M | Dihydrofuran-3(2H)-one | BPK-29 hydrochloride | pppApG | MEIS-IN-2 | 2′-O-Methyl-8-methyl guanosine | Altertoxin I | Lithospermoside | Acitazanolast | FLAG peptide | [Des-Tyr1]-Met-Enkephalin | α-Carotene | myo-Inositol trispyrophosphate hexa-triethylamine | Myt1-IN-2 | Simetride
品牌介紹:
• MCE (MedChemExpress) 擁有200 多種全球僅有化合物庫,我們致力于為全球科研客戶提供前沿的高品質小分子活性化合物;
• 50,000 多種高選擇性抑制劑、激動劑涉及各熱門信號通路及疾病領;
• 產(chǎn)品種類涵蓋各種重組蛋白,多肽,常用試劑盒 ,更有 PROTAC、ADC 等特色產(chǎn)品,廣泛應用于新藥研發(fā)、生命科學等科研項目;
• 提供虛擬篩選,離子通道篩選,代謝組學分析檢測分析,藥物篩選等專業(yè)技術服務;
• 設有專業(yè)的實驗中心和嚴格的質控、驗證體系;
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各項質檢報告,確保產(chǎn)品的高純度、高品質;
• 產(chǎn)品的生物活性多經(jīng)各國客戶實驗驗證;
• Nature, Cell, Science 等多種頂級期刊及制藥 Patent 收錄了MCE客戶的科研成果;
• 專業(yè)團隊跟蹤最新的制藥及生命科學研究進展,為您提供全球新的活性化合物;
• 與世界各大制藥公司及著名科研機構建立了長期的合作。